Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 2Urinary Bladder Neoplasms 1Stress Disorders, Post-Traumatic 1Stomach Neoplasms 1Prostatic Neoplasms 1Pain 1Neoplasms 1Muscle-invasive Bladder Cancer 1Mesothelioma, Malignant 1Mesothelioma 1Melanoma 1Locally Advanced Colorectal Cancer 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Hemorrhage 1Bites and Stings 1

Interventions

tremelimumab 1pembrolizumab 1enfortumab vedotin 1durvalumab 1Watchful Waiting 1Radiotherapy 1Palliative Care 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Muscle-invasive Bladder Cancer × Palliative Care × Clear all
NCT06686381 2025-02-05

Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W

American University of Beirut Medical Center

Phase 2 Not yet recruiting
80 enrolled
Genitourinary

Muscle-invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡